Addus HomeCare (NASDAQ:ADUS – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” rating in a research report issued on Tuesday.
A number of other equities research analysts have also weighed in on the stock. TD Cowen boosted their price objective on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a report on Thursday, August 8th. Macquarie restated an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research note on Monday, November 4th. Oppenheimer lifted their target price on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. Stephens upped their price objective on Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research report on Wednesday, November 6th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $136.00 target price on shares of Addus HomeCare in a research report on Thursday, November 14th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $131.63.
Read Our Latest Research Report on Addus HomeCare
Addus HomeCare Trading Down 0.7 %
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last issued its earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. During the same quarter last year, the business earned $1.03 earnings per share. The company’s quarterly revenue was up 7.1% on a year-over-year basis. Research analysts anticipate that Addus HomeCare will post 4.58 EPS for the current fiscal year.
Insider Buying and Selling at Addus HomeCare
In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of the stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the transaction, the director now owns 3,366 shares of the company’s stock, valued at $429,165. This represents a 12.93 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO R Dirk Allison sold 12,500 shares of the stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the completion of the sale, the chief executive officer now owns 141,897 shares of the company’s stock, valued at approximately $17,476,034.52. The trade was a 8.10 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 13,500 shares of company stock valued at $1,668,265. Corporate insiders own 4.60% of the company’s stock.
Institutional Investors Weigh In On Addus HomeCare
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Texas Permanent School Fund Corp boosted its position in shares of Addus HomeCare by 0.6% during the 2nd quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company’s stock worth $1,636,000 after purchasing an additional 82 shares during the period. Arizona State Retirement System lifted its position in shares of Addus HomeCare by 2.0% during the 2nd quarter. Arizona State Retirement System now owns 4,543 shares of the company’s stock worth $527,000 after purchasing an additional 87 shares during the last quarter. UMB Bank n.a. boosted its position in shares of Addus HomeCare by 64.2% during the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after acquiring an additional 88 shares in the last quarter. Inspire Investing LLC boosted its holdings in Addus HomeCare by 3.3% in the third quarter. Inspire Investing LLC now owns 3,111 shares of the company’s stock valued at $414,000 after purchasing an additional 100 shares in the last quarter. Finally, New York State Teachers Retirement System grew its position in shares of Addus HomeCare by 1.2% in the 3rd quarter. New York State Teachers Retirement System now owns 8,510 shares of the company’s stock valued at $1,132,000 after buying an additional 100 shares during the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.
About Addus HomeCare
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Recommended Stories
- Five stocks we like better than Addus HomeCare
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Netflix Is On Track To Hit $1,000 By Christmas
- 3 Warren Buffett Stocks to Buy Now
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.